Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Everyday Seasonal Positions That Compensate Fairly in the US- Vote in favor of your Number one Kind of Gems
- Family Holiday spots
- Which salad do you believe is a definitive group pleaser? Vote!
- The Main 10 Natural life Protection Associations
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- Space Condos to Lift Your Metropolitan Living
- Spots To Go Birdwatching All over the Planet
